Suggestions

THC · NYSE

TENET HEALTHCARE CORP

Private beta

Sector unavailable · Industry unavailable

$263.69

+0.09%

Close on Sep 11, 2026

Insufficient Data

Updated 12/19/2023

Long-term research evidence only. No price targets, no trading signals, no recommendations.

Investment Report Card

TENET HEALTHCARE CORP

Sector unavailable · Data confidence partial

77 / 100

Rank #46 of 1,152 qualified companies

Top 7% · Worth a Closer Look

Risk Intelligence

Core Model
B+

82 / 100

Insufficient Data

How strong and defensively sound is the company?

Above average on this measure.

Long-Term Potential

Research Model
D+

54 / 100

Insufficient Data

Does the business have the characteristics needed to create value over many years?

Weaker than most covered companies on this measure.

Fundamental Momentum

Research Model
B−

72 / 100

Insufficient Data

Is the underlying business getting stronger or weaker?

Above average on this measure.

Ownership Intelligence

Supplemental Intelligence
A

94 / 100

Positive disclosed activity

What are important owners actually doing?

Among the strongest readings on this measure.

Valuation Intelligence

Research Model
B−

74 / 100

Very Attractive

Is today's price reasonable?

Above average on this measure — and valuation is researched separately from the Suggested Investment Score.

Capital Returns Intelligence

Research Model
A−

87 / 100

Exceptional Capital Returns

How effectively does the company reward shareholders?

Among the strongest readings on this measure — and capital returns are researched separately from the Suggested Investment Score.

Why it stands out

  • More disclosed holders are new or increasing than reducing or exiting.
  • Attractive valuation: the stock reads 74 out of 100 on Valuation Intelligence (Very Attractive) relative to its own history and comparable companies.

What holds it back

No weakening evidence is recorded in today's readings.

Long-term view

TENET HEALTHCARE CORP scores 54 on Long-Term Potential (D+), described by the research model as insufficient data. This describes business characteristics only — it is not a forecast of future returns.

Ownership view

Disclosed ownership evidence reads 94 (A): Positive disclosed activity. 2 tracked managers disclosed a position in the latest reporting period. Ownership filings are historical disclosures, not signals.

Valuation view

TENET HEALTHCARE CORP reads 74 out of 100 on Valuation Intelligence, recorded as Very Attractive. The stock currently trades above most of its own recent valuation history and below comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value. Valuation Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.

Capital returns view

TENET HEALTHCARE CORP reads 87 out of 100 on Capital Returns Intelligence (Exceptional Capital Returns), reflecting a share count falling about 5.0% a year. Direct capital returns are limited because the company continues reinvesting most of its cash. Capital Returns Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.

What changed

No meaningful recorded changes in the stored history.

Risk Intelligence is a core model, Long-Term Potential, Fundamental Momentum, Valuation Intelligence and Capital Returns Intelligence are research models, and Ownership Intelligence is supplemental descriptive evidence. Valuation Intelligence and Capital Returns Intelligence each contribute 0% to the Suggested Investment Score. Nothing here is a recommendation.

Compare THC with other companies

Appears in

Rule-based membership

Membership means the company satisfied a published rule on the latest research build. It is not a recommendation.

About a minute to read

The 60-Second Investment Brief

Written from stored research readings only. No hype. No trading signals. Just better evidence.

Why it's interesting

TENET HEALTHCARE CORP (THC) scores 77 out of 100 and ranks #46 of 1,152 qualified companies today. That places it in the top 7% of ranked companies. The stored tier for that score is worth a closer look.

Business strength

Risk Intelligence reads 82 out of 100 (B+), recorded as insufficient data. Above average on this measure.

Long-term opportunity

Long-Term Potential reads 54 out of 100 (D+), recorded as insufficient data. Weaker than most covered companies on this measure.

What's improving or weakening

Fundamental Momentum reads 72 out of 100 (B−), recorded as insufficient data. Above average on this measure.

What important owners are doing

Ownership Intelligence reads 94 out of 100 (A), recorded as positive disclosed activity. Among the strongest readings on this measure.

What kind of price you'd be paying

Valuation currently appears favourable: Valuation Intelligence reads 74 out of 100 (B−), recorded as Very Attractive. TENET HEALTHCARE CORP reads 74 out of 100 on Valuation Intelligence, recorded as Very Attractive. The stock currently trades above most of its own recent valuation history and below comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value. Valuation Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.

How the company rewards shareholders

Capital Returns Intelligence reads 87 out of 100 (A−), recorded as Exceptional Capital Returns. TENET HEALTHCARE CORP reads 87 out of 100 on Capital Returns Intelligence (Exceptional Capital Returns), reflecting a share count falling about 5.0% a year. Direct capital returns are limited because the company continues reinvesting most of its cash. Capital Returns Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.

What could go wrong

No weakening factors are recorded in today's stored readings, and data confidence is partial. Absence of a recorded weakness is not evidence of safety.

Bottom line

Its strongest recorded evidence is Risk Intelligence and Ownership Intelligence. Long-Term Potential remains the main area to watch. Separately from the score, valuation reads very attractive at today's price.

Composite discovery model

Pro Investor Score

Pro Investor Score™

77 / 100

Worth a Closer Look

A 0–100 composite discovery score combining Risk Intelligence, Long-Term Potential, Fundamental Momentum, and Ownership Intelligence. It helps rank qualified companies for further research and does not predict future returns.

Rank
#46 of 694
Percentile
Top 10%
Ranking updated
September 12, 2026
Rank unchanged. Rank unchanged.
Risk Intelligence
82

30% contribution

Long-Term Potential
54

30% contribution

Fundamental Momentum
72

20% contribution

Ownership Intelligence
94

20% contribution

Ownership Intelligence

94 / 100 · Strong · 20% of the Pro Investor Score

SUPPLEMENTAL / DESCRIPTIVE INTELLIGENCE

Coverage: Partial Coverage

Elite Investor Activity
Insufficient Data

50% of Ownership Intelligence · 10% of the total score

No reliably mapped professional-manager filings are stored, so this evidence is unavailable rather than neutral.

Institutional Activity
94 · Strong

20% of Ownership Intelligence · 4% of the total score

Broad institutional evidence from resolved filings is strong.

Insider Activity
Insufficient Data

15% of Ownership Intelligence · 3% of the total score

No discretionary insider transactions are stored for this company, so this evidence is unavailable rather than neutral.

Strategic Ownership
Insufficient Data

15% of Ownership Intelligence · 3% of the total score

No qualifying major-holder filings are stored, so this evidence is unavailable rather than neutral.

Ownership Intelligence summarizes publicly disclosed activity among professional investment managers, broader institutions, company insiders, and significant strategic owners. It adds context to investment research but is not a validated predictor of future performance. Ownership information is publicly reported with a delay; the latest applicable reporting period is 2026-06-30, publicly disclosed 9/11/2026. Congressional activity is unavailable pending legal review and contributes nothing to this reading.

Why it ranks here

  • Strong risk profile

    Risk Intelligence ranks in the top 6% of qualified companies, with normal_risk price risk.

  • Improving fundamentals

    Recent reported business trends rank among the strongest in the qualified universe.

  • Strong ownership evidence

    Disclosed institutional activity evidence is favourable relative to other qualified companies. Ownership evidence is descriptive and reported with a delay.

What holds it back

  • Ownership Intelligence — Partial Coverage

    Only part of the ownership evidence is available for this company. Missing evidence is left missing rather than replaced with a neutral value.

COMPOSITE DISCOVERY MODEL — RESEARCH STAGE · Data coverage Good. Rankings are recalculated daily using the latest available information. Individual components may update at different frequencies based on when new financial and ownership data becomes available.

Researched separately

Valuation Intelligence 74 · Very Attractive

RESEARCH MODEL

Valuation Intelligence is currently researched separately and does not affect the Suggested Investment Score or daily ranking.

Researched separately

Capital Returns Intelligence 87 · Exceptional Capital Returns

RESEARCH MODEL

Capital Returns Intelligence is researched separately and contributes 0% to the Suggested Investment Score, the daily rank or any ranking event.

Score explanation

Why this company scores the way it does

Four research areas carry fixed weights. Each area is compared against every other eligible company, then weighted. The four contributions below add to 77.2 of the stored score (77.2).

  • Risk Intelligence

    30% of the score · contributes 28.5 points

    How strong and defensively sound is the company?

    Stands at the 95 percentile of eligible companies · stored reading 82 · 37% of this company’s total score

    How financially sturdy the company has been when conditions turned against it.

    How this area is measured

    Risk Intelligence reads stored balance-sheet strength, historical downside behaviour and the company's price-risk grouping. A stronger reading describes past resilience; it does not protect against future losses.

    Full methodology
  • Long-Term Potential

    30% of the score · contributes 15.0 points

    Does the business have the characteristics needed to create value over many years?

    Stands at the 50 percentile of eligible companies · stored reading 54 · 19% of this company’s total score

    Whether the business has the durable characteristics long-term owners look for.

    How this area is measured

    Long-Term Potential reads durability characteristics such as profitability consistency, cash generation and reinvestment capability over multiple reported periods.

    Full methodology
  • Fundamental Momentum

    20% of the score · contributes 17.3 points

    Is the underlying business getting stronger or weaker?

    Stands at the 87 percentile of eligible companies · stored reading 72 · 22% of this company’s total score

    Whether the reported business results have been getting stronger or weaker.

    How this area is measured

    Fundamental Momentum compares recent reported fundamentals with the company's own earlier periods, so improvement or deterioration is measured against its history rather than against a forecast.

    Full methodology
  • Ownership Intelligence

    20% of the score · contributes 16.4 points

    What are important owners actually doing?

    Stands at the 82 percentile of eligible companies · stored reading 94 · 21% of this company’s total score

    What large reporting owners have actually been doing with their positions.

    How this area is measured

    Ownership Intelligence reads public ownership filings: how many tracked reporting owners hold the company, and whether they were adding, holding, reducing or exiting in the latest disclosed period.

    Full methodology

What is helping the score

  • Risk Intelligence95 percentile, adding 28.5 points.
  • Fundamental Momentum87 percentile, adding 17.3 points.
  • Ownership Intelligence82 percentile, adding 16.4 points.

What deserves attention

No research area currently sits in the weaker range. That is not evidence of low risk.

Outside the score

Additional research — not currently included in the primary Suggested Investment Score.

  • Valuation IntelligenceTENET HEALTHCARE CORP reads 74 out of 100 on Valuation Intelligence, recorded as Very Attractive. The stock currently trades above most of its own recent valuation history and below comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value.
  • Capital Returns IntelligenceTENET HEALTHCARE CORP reads 87 out of 100 on Capital Returns Intelligence (Exceptional Capital Returns), reflecting a share count falling about 5.0% a year. Direct capital returns are limited because the company continues reinvesting most of its cash.

Pro Investor Intelligence™

Reported by insiders, large shareholders and professional funds. Shown beside our research, never blended into it.

Loading professional-investor activity…

Stored snapshots only

What changed

Research-score history available since September 2026.

Stored research history does not yet cover a full 30 days comparison for this company.

A change is reported as meaningful at 8 score points, 5 rank places, or any change of research classification. Nothing here is a recommendation to buy or sell.

Learn the metrics on this page

Plain-English definitions, with the formula and the limitations of each measure.

Fifth research lens · outside the score

Valuation Intelligence

Valuation Intelligence

Is today's price reasonable?

Valuation Intelligence is currently researched separately and does not affect the Suggested Investment Score or daily ranking.

74/ 100

Very Attractive

RESEARCH MODEL
Excellent coverage

Compared with its history

38

Elevated

Is this company expensive or inexpensive compared with its own history?

Compared with peers

78

Very Attractive

How expensive is this stock compared with similar companies?

Earnings & cash flow

93

Very Attractive

How much financial output does an investor receive relative to the price paid?

Growth-adjusted

100

Very Attractive

Does the company's growth help justify the valuation investors are paying?

TENET HEALTHCARE CORP reads 74 out of 100 on Valuation Intelligence, recorded as Very Attractive. The stock currently trades above most of its own recent valuation history and below comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value.

Price data through September 11, 2026 · Financial data through the quarter ended June 30, 2026

Valuation history

Stored readings only. The dashed line is this company's own median for the selected measure.

Only one stored valuation reading exists so far, so there is nothing to chart yet. Valuation history builds forward from activation rather than being reconstructed.

Current P/E 9.5x · own median 9.6x · peer median 19.6x

Valuation is inherently uncertain. A stock that appears inexpensive can continue falling, and a stock that appears expensive can continue rising. Valuation Intelligence provides context about the price investors are paying — it does not predict short-term market movements, and it never produces a fair value, a price target or a buy or sell range. Model VALUATION_INTELLIGENCE_V1.

Sixth research lens · outside the score

Capital Returns Intelligence

Capital Returns Intelligence

How effectively does the company reward shareholders?

Capital Returns Intelligence is researched separately and contributes 0% to the Suggested Investment Score, the daily rank or any ranking event.

87/ 100

Exceptional Capital Returns

RESEARCH MODEL
Excellent coverage

Dividend Quality

Not Applicable — No Dividend

Dividend reliability

This company currently retains rather than distributes cash through dividends. Capital Returns Intelligence therefore places more emphasis on its other measurable shareholder-return behaviors according to the frozen V1 methodology.

Buyback Effectiveness

97

Exceptional Capital Returns

Do buybacks actually reduce shares?

Dilution Control

90

Exceptional Capital Returns

Is your ownership share protected?

Capital Return Sustainability

76

Strong Capital Returns

Can the cash flow support it?

Shareholder Yield

78

Strong Capital Returns

Cash returned versus company value

TENET HEALTHCARE CORP reads 87 out of 100 on Capital Returns Intelligence (Exceptional Capital Returns), reflecting a share count falling about 5.0% a year. Direct capital returns are limited because the company continues reinvesting most of its cash.

This company currently retains rather than distributes cash through dividends. Capital Returns Intelligence therefore places more emphasis on its other measurable shareholder-return behaviors according to the frozen V1 methodology.

How returned cash was used

Dividends $0.00 · net repurchases $1.65B · total returned $1.65B · 54% of free cash flow

Price data through September 11, 2026 · Financial data through the quarter ended June 30, 2026

Capital returns history

Stored readings only. History builds forward from activation rather than being reconstructed.

Only one stored reading exists for this measure so far, so there is nothing to chart yet.

Why higher yield isn't always better

A very high dividend yield may reflect a falling share price or an unsustainable payout. Capital Returns Intelligence emphasizes consistency and sustainability rather than simply rewarding the highest yield.

Why buybacks can be misleading

Announced or gross buyback spending does not always mean shareholders are gaining ownership. Companies can simultaneously issue shares through employee compensation or acquisitions. Suggested Investments therefore considers actual share-count changes alongside repurchase spending.

What these terms mean
Dividend Yield
The annual dividend relative to the current share price.
Payout Ratio
The share of company earnings used to pay dividends.
Free Cash Flow Payout
How much of the company's available cash is being used for dividends.
Share Repurchases
When a company buys back its own stock.
Dilution
When the number of shares increases, reducing each existing share's percentage ownership of the company.
Shareholder Yield
A combined view of dividends and net share repurchases relative to the company's market value.

Capital Returns Intelligence describes how a company returns capital to shareholders. It is not a measure of stock-price performance, it does not predict future returns, and a strong reading is never a recommendation to buy. Dividends and repurchases can be reduced or stopped at any time. Model CAPITAL_RETURNS_INTELLIGENCE_V1, contributing 0% to the Pro Investor Score.

Stored daily snapshots only

Ranking history

Stored Suggested Investment ranking history
Today#46Score 77
30 days agoNot rankedNo stored score
90 days agoNot rankedNo stored score
First suggestedSeptember 12, 2026
Highest rank#46

In the company’s own words

What this company does

Tenet Healthcare Corporation ("Tenet") is a diversified healthcare services company with its headquarters in Dallas, Texas, and a Global Business Center ("GBC") in the Philippines that supports various enterprise-wide administrative functions. We operate our expansive, nationwide care delivery network through direct and indirect subsidiaries, as well as downstream partnerships and joint ventures; the terms "we," "our" and "us," as used in this report and unless otherwise stated or indicated by the context, refer to Tenet and these entities. Our business is organized into two separate reporting segments – Hospital Operations and Services ("Hospital Operations") and Ambulatory Care.

At December 31, 2025, our Hospital Operations segment was comprised of: (1) 50 acute care and specialty hospitals, a network of employed physicians, and 132 outpatient facilities, including urgent care centers (each, a "UCC"), imaging centers, off-campus hospital emergency departments ("EDs") and micro hospitals; and (2) the revenue cycle management and value based care services we provide to hospitals, health systems, physician practices, employers and other clients through Conifer Health Solutions, LLC. Our Ambulatory Care segment is comprised of the operations of USPI Holding Company, Inc. (together with its subsidiaries, "USPI"), which held ownership interests in 533 ambulatory surgery centers (each, an "ASC") and 26 surgical hospitals at December 31, 2025. Additional information about our reporting segments is provided below; statistical data for the segments can be found in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of Part II of this report ("MD&A").

In 2025, we continued to strengthen our organization and expand the care we provide while remaining committed to quality, safety and operational excellence. We enhanced access to higher-acuity services in our communities, advanced ambulatory surgery care, invested in state-of-the-art technology and facilities, and welcomed new team members and physician partners. In September 2025, we opened the newly constructed, 54-bed Florida Coast Medical Center in Port St. Lucie, Florida. This acute care hospital offers specialized services, including advanced cardiac care, diagnostic services, an emergency care department, general surgery, neurosciences, orthopedics, robotics and urology.

Our subsidiaries operated 50 acute care and specialty hospitals serving primarily urban and suburban communities in eight states at December 31, 2025. We had sole ownership of 46 of these hospitals, two were owned by entities that are majority owned by a Tenet subsidiary, and two were owned by third parties and leased by our wholly owned subsidiaries.

Quoted from the business section of this company’s 10-K filed February 17, 2026. Read the filing

Four distinct intelligence areas

The IA view

Risk Intelligence

Production core

82

Fundamentally Qualified

No prior period to compare

Business Quality qualification score from the locked IA Defensive Research Core. Price Risk stays a separate category and is never blended in.

As of Sep 11, 2026

Long-Term Potential

Research model

54

Ordinary Compounder

No prior period to compare

Durable business economics and reinvestment characteristics. Independent external validation is pending.

As of Sep 11, 2026

Fundamental Momentum

Research model

72

Accelerating

No prior period to compare

Direction and breadth of change in underlying business fundamentals. Not a price-momentum signal.

As of Sep 11, 2026

Elite Investor Activity

Supplemental

Insufficient Data

No prior period to compare

Too few tracked managers disclosed a position to describe consensus.

Intelligence history

Not enough stored history to chart THC yet. A company needs at least two published research or ownership periods before a trend can be shown.

Share price

THC price history

Closing prices adjusted for splits and dividends. Past prices do not indicate future results.

6M change
+17.3%
1Y change
+36.4%
3Y change
+271.5%
5Y change
+259.7%
Max change
+587.6%

Last stored close $263.69 · +36.4% over the selected range · 52 sessions shown

Balanced evidence

Why IA likes it

  • More disclosed holders are new or increasing than reducing or exiting.

Risk and uncertainty

What IA doesn’t like

  • No specific negative evidence is available. This is not evidence of low risk.

What would change our view

  • Business Quality falling below the frozen qualification threshold.
  • Price Risk moving to a less favorable category.
  • A sustained reversal in the Fundamental Momentum research evidence.
  • New material public ownership disclosures.

Public filings · descriptive only

Elite Investor Activity

Reporting holders

7

New holders

6

Increasing

0

Reducing

1

Exiting

0

Coverage

Excellent

Positive disclosed activity · Report period 2022-12-31 · Public 12/19/2023

ManagerChangePortfolio weightRankDisclosed

Insufficient high-confidence manager coverage.

Objective stored changes

What changed

No qualifying changes are recorded for this company in the stored research and filing history.

Ownership timeline

No high-confidence public ownership events are available.

General research only. Not personalized advice. Public filings may be delayed, amended, incomplete, or reflect positions that have changed since the reporting date.